Under copyright Constraint(s) on Use: This work is protected by the U.S. Copyright Law (Title 17, U.S.C.). Use of this work beyond that allowed by "fair use" requires written permission of the UC Regents. Responsibility for obtaining permissions and any use and distribution of this work rests exclusively with the user and not the UC San Diego Library. Inquiries can be made to the UC San Diego Library program having custody of the work. Use: This work is available from the UC San Diego Library. This digital copy of the work is intended to support research, teaching, and private study.
Rights Holder and Contact
UC Regents
Description
Dr. Rastetter holds a Bachelor of Science from MIT and earned a Masters and PhD degree in Chemistry from Harvard University. After leaving teaching on the East Coast, he joined Genentech Inc. (1982-1986), where he worked as a scientist and later as director of corporate ventures. He joined IDEC Pharmaceuticals in 1986, where he held a number of senior executive positions, including Chief Executive Offider for IDEC (1986-2002) and Executive Chairman of Biogen IDEC (2003-2005). At IDEC, Dr. Rastetter drew on his background in science to support management decisions, and he was instrumental in the company’s decision to develop Rituxan which was co-marketed with Genentech. He served on the board of directors at Illumina Inc. and been involved in entrepreneurial and investment activities as a partner for the venture capital firm Venrock, where he participated in the development of companies like Argonaut, Genencor, and Spiros Development Corporation. He has held faculty positions at the MIT and Harvard, and also sat on the board of the California Healthcare Institute. Born digital Special Collections & Archives, UC San Diego, La Jolla, 92093-0175 (https://lib.ucsd.edu/sca)
If you're wondering about permissions and what you can do with this item, a good starting point is the "rights information" on this page. See our terms of use for more tips.
Share your story
Has Calisphere helped you advance your research, complete a project, or find something meaningful? We'd love to hear about it; please send us a message.
